[Myocardial Infarction in the population aged 25-74 in Navarra. Incidence, lethality and treatment in the period 1997-98. IBERICA study].
暂无分享,去创建一个
[1] A. Llácer,et al. Mortalidad en España en 1998. Evolución en la década 1989-1998. II. Mortalidad general, principales causas de muerte por sexo y edad , 2002 .
[2] J. García,et al. Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda)* , 2001 .
[3] R. Moreno. Manejo del infarto agudo de miocardio en España. Diferencias interregionales en la actualidad según el registro IBERICA , 2001 .
[4] F. Arós,et al. Manejo del infarto de miocardio en España (1995-99). Datos del registro de infartos de la Sección de Cardiopatía Isquémica y Unidades Coronarias (RISCI) de la Sociedad Española de Cardiología , 2001 .
[5] W. Rogers,et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.
[6] F. Arós,et al. VARIABILIDAD EN EL MANEJO Y PRONOSTICO A CORTO Y MEDIO PLAZO DEL INFARTO DE MIOCARDIO EN ESPANA : EL ESTUDIO PRIAMHO , 1999 .
[7] R. Schiele,et al. [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany]. , 1999, Zeitschrift fur Kardiologie.
[8] H. Tunstall-Pedoe,et al. Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.
[9] Harlan M. Krumholz,et al. Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? , 1999 .
[10] A. Cabadés,et al. CARACTERISTICAS, MANEJO Y PRONOSTICO DEL PACIENTE CON INFARTO AGUDO DE MIOCARDIO EN LA COMUNIDAD VALENCIANA EN 1995 : RESULTADOS DEL REGISTRO PRIMVAC (PROYECTO DE REGISTRO DE INFARTO AGUDO DE MIOCARDIO DE VALENCIA, ALICANTE Y CASTELLON) , 1999 .
[11] H. Tunstall-Pedoe,et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. , 1999, Lancet.
[12] G Barbash,et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.
[13] J. Marrugat,et al. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990–1992 , 1998 .
[14] J. Ferrières,et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. , 1997, Journal of the American College of Cardiology.
[15] J. Lupón,et al. Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempos de Espera. , 1997, Journal of the American College of Cardiology.
[16] D Kromhout,et al. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .
[17] M A Hlatky,et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. , 1996, The New England journal of medicine.
[18] C. Albert,et al. Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.
[19] M. R. Ramos,et al. [Trends in mortality from cardiovascular diseases in Andalucia: 1975-1992]. , 1996 .
[20] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[21] B. McNeil,et al. Variation in the use of cardiac procedures after acute myocardial infarction. , 1995, The New England journal of medicine.
[22] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .
[23] R. M. Rubison,et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.
[24] M. Rué,et al. [Tendencies of mortality from cardiovascular diseases in Catalonia: 1975-1992]. , 1993, Medicina clinica.
[25] G. Lamas,et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.
[26] J. O. Carnicer,et al. FIBRINOLISIS PREHOSPITALARIA EN EL INFARTO AGUDO DE MIOCARDIO , 1991 .
[27] F. Rodríguez Artalejo,et al. Recent coronary heart disease mortality trends in Spain. , 1990, International journal of epidemiology.